July 10, 2023 Columns by Ed Tobias MS news notes: New gadolinium agent, myelin, high-efficacy DMTs Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Testing a new MRI contrast agent One…
July 7, 2023 Columns by Ed Tobias We need more advertisements portraying people with disabilities I nearly jumped for joy — well, I would’ve if I could’ve — when I saw a new TV commercial for the Expedia travel company the other day. It shows a woman in winter who’s obviously had…
July 3, 2023 Columns by Ed Tobias MS news notes: Stem cell therapy, genetic variant, diet Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Another study shows positive results with stem…
June 30, 2023 Columns by Ed Tobias My COVID-19 antibodies are still in my blood, but does it matter? It’s been almost two and a half years since my first COVID-19 vaccine — eight months since my most recent booster — and my COVID-19 antibodies seem to still be doing their thing. I know this because,…
June 26, 2023 Columns by Ed Tobias MS news notes: Vaccinations, sex coping strategies, myelin repair Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: MS experts offer more…
June 23, 2023 Columns by Ed Tobias A good doctor-patient relationship matters to people with MS “What can Dr. Crayton help you with today?” I was starting my annual multiple sclerosis (MS) checkup with my neurologist, and before I met with her, I got this question from her MS nurse. I…
June 20, 2023 Columns by Ed Tobias MS news notes: Clemastine, MS retrospective, PIPE-791 Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Myelin repair and clemastine…
June 16, 2023 Columns by Ed Tobias Air4All hopes to make flying with a wheelchair easier I’ve done quite a bit of flying, for business and pleasure, over the 42 years I’ve lived with multiple sclerosis (MS). It’s not easy traveling by air with my scooter, and I can’t imagine…
June 12, 2023 Columns by Ed Tobias MS news notes: Foralumab, Ocrevus, Kesimpta, exercise Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Foralumab shows early positive…
June 9, 2023 Columns by Ed Tobias Could a digital bridge to link brain and spinal cord help those with MS? We all know that the difficulty many of us with multiple sclerosis (MS) have walking can be caused by lesions that damage the nerves along the spinal cord. What if an electronic bridge could…
June 5, 2023 Columns by Ed Tobias MS news notes: Frexalimab, vidofludimus calcium, Briumvi Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Is CD40L a better…
June 2, 2023 Columns by Ed Tobias Let’s talk facts about MS and COVID-19 vaccines Since the early days of the COVID-19 vaccination program, disinformation claiming that the vaccines can induce multiple sclerosis (MS) has swirled around social media. Recently, there’s been a resurgence of this type of post, sparked by a…
May 30, 2023 Columns by Ed Tobias MS News Notes: EBV, nabiximols, MRT-6160 Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: A closer look at…
May 26, 2023 Columns by Ed Tobias Sure, there are benefits to having a pet. But with MS, is it wise? I’m just back from walking our dog. My wife, Laura, rescued him about a year ago, and when she heard his name was Toby, like Tobias, she thought it was a sign that he was the…
May 22, 2023 Columns by Ed Tobias MS news notes: Stem cell studies, Ocrevus, fenebrutinib, and more Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Early stem cell transplants…
May 19, 2023 Columns by Ed Tobias Want to take your MS to the beach? Memorial Day, the unofficial start of summer vacation in the U.S., is fast approaching. It’s almost time for some summer beach fun — if we can get there. Beaches can be difficult, if not impossible, to access for many…
May 15, 2023 Columns by Ed Tobias MS news notes: Facial surgery, UK MS rate, omega-3, remyelination Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Surgical treatment of facial…
May 12, 2023 Columns by Ed Tobias My 5 wishes for the future of multiple sclerosis A recent post on the MS-Selfie blog asks and answers this question: What is the “greatest unmet need” concerning multiple sclerosis (MS)? Professor Gavin Giovannoni, the London-based neurologist who writes that blog, lists five unmet…
May 8, 2023 Columns by Ed Tobias MS news notes: Ocrevus, assistive devices, virtual reality, Briumvi Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Study: Starting Ocrevus early…
May 5, 2023 Columns by Ed Tobias Artificial intelligence moves into the MS exam room. But should it? Is artificial intelligence (AI) intelligent enough to help make a diagnosis of multiple sclerosis (MS)? Apparently so, and more. In the United Kingdom, a project named AssistMS is studying whether AI can be…
March 28, 2024 Columns by Benjamin Hofmeister Multiple sclerosis awareness is for people with MS, too